-The Times of India NEW DELHI: The government has invoked special powers under the law to prohibit stent makers from withdrawing their products from the market for the next six months. Amid reports that several manufacturers, including Abbott and Medtronic, are seeking to withdraw premium, high-priced stents from the Indian market on account of the price cap imposed by National Pharmaceutical Pricing Authority (NPPA), the government has directed companies to maintain production,...

-Scroll.in Arsenic levels in water have been as high as 3,880 parts per billion in parts of the state. Pollution standards cite 50 parts per billion as harmful. It is a day like any other at Mahavir Cancer Sansthan. The driveway is lined with people who have travelled a long way to get to this charitable hospital in Patna. Families sit huddled, holding their bags close. The lobby is even more crowded,...

-The Times of India Cancer drugs, being the top focus for research and development, corner the lion's share of medicines launched globally, yet only a handful make it to developing countries like India. Only seven oncology drugs were introduced in India over five years (2010-2014), when nearly 50 breakthrough therapies were rolled out globally. The disparity in availability of oncology therapies becomes even more stark over a 10-year period (2006-2016), with not even...

-The Indian Express The rights-based approach departs from the ‘assurance-based approach’ of the new National Health Policy, which essentially perpetuates the status quo, explains The Indian Express. Since the time the Mental Health Bill was introduced in Rajya Sabha in 2013, decriminalisation of suicide has been its calling card. However, the legislation travels beyond just that colonial era relic, assuming a rights-based approach to mental healthcare, and creating circumstances for removal of...

-The Hindu Business Line By trying to appear more women-friendly than is necessary, the law may deter industry from employing women altogether The amendment to the maternity Bill, long overdue, calls for some serious reconsideration due to its skewed philosophy. While the most prominent flaw is its emphasis on employees in the new-age services sector, there are several other shortcomings. What is wrong Firstly, the need for expansion of the existing benefit lacks scientific basis....